Prognostic significances of overexpression MYC and/or BCL2 in R-CHOP-treated diffuse large B-cell lymphoma: A Systematic review and meta-analysis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic significances of overexpression MYC and/or BCL2 in R-CHOP-treated diffuse large B-cell lymphoma: A Systematic review and meta-analysis
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-04-13
DOI
10.1038/s41598-018-24631-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- B-cell Function Gene Mutations in Diffuse Large B-cell Lymphoma: A Retrospective Cohort Study
- (2017) Peng-Peng Xu et al. EBioMedicine
- Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL
- (2016) K. J. Savage et al. BLOOD
- Approach to the diagnosis and treatment of high-grade B-cell lymphomas withMYCandBCL2and/orBCL6rearrangements
- (2016) Pierre Sesques et al. BLOOD
- Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704
- (2016) Soham D. Puvvada et al. BRITISH JOURNAL OF HAEMATOLOGY
- MYCtranslocation and/or BCL 2 protein expression are associated with poor prognosis in diffuse large B-cell lymphoma
- (2016) Keisuke Kawamoto et al. CANCER SCIENCE
- Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis
- (2015) Christina Howlett et al. BRITISH JOURNAL OF HAEMATOLOGY
- Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies
- (2015) David W. Scott et al. JOURNAL OF CLINICAL ONCOLOGY
- Synergistic induction of apoptosis in high-risk DLBCL by BCL2 inhibition with ABT-199 combined with pharmacologic loss of MCL1
- (2015) L Li et al. LEUKEMIA
- Dual expression of MYC and BCL2 proteins predicts worse outcomes in diffuse large B-cell lymphoma
- (2015) Kelli M. Clark Schneider et al. LEUKEMIA & LYMPHOMA
- Clinical features, tumor biology and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP
- (2015) Zijun Y Xu-Monette et al. MODERN PATHOLOGY
- B-Cell Receptor Signaling in Diffuse Large B-Cell lymphoma
- (2015) Ryan M. Young et al. SEMINARS IN HEMATOLOGY
- Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era
- (2014) R. Vaidya et al. ANNALS OF ONCOLOGY
- MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab
- (2014) Anamarija M. Perry et al. BRITISH JOURNAL OF HAEMATOLOGY
- Double hit lymphoma: the MD Anderson Cancer Center clinical experience
- (2014) Yasuhiro Oki et al. BRITISH JOURNAL OF HAEMATOLOGY
- BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma
- (2014) Samantha L. Kendrick et al. HUMAN PATHOLOGY
- MYC Expression in Concert with BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients with Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
- (2014) Li-Xu Yan et al. PLoS One
- MYC protein expression is associated with poor prognosis in diffuse large B cell lymphoma patients treated with RCHOP chemotherapy
- (2014) Min Zhou et al. TUMOR BIOLOGY
- MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
- (2013) H. Horn et al. BLOOD
- Diffuse large B-cell lymphoma
- (2013) Maurizio Martelli et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- MYC translocation partner gene determines survival of patients with large B-cell lymphoma with MYC- or double-hit MYC/BCL2 translocations
- (2013) Mette Ø. Pedersen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Pathogenesis of Human B Cell Lymphomas
- (2012) Arthur L. Shaffer et al. Annual Review of Immunology
- Growing Importance of MYC/BCL2 Immunohistochemistry in Diffuse Large B-Cell Lymphomas
- (2012) Michael Pfreundschuh JOURNAL OF CLINICAL ONCOLOGY
- Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
- (2012) Tina Marie Green et al. JOURNAL OF CLINICAL ONCOLOGY
- Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
- (2012) Nathalie A. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell Lymphomas
- (2012) Michael J. Kluk et al. PLoS One
- Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium
- (2011) G. Salles et al. BLOOD
- BCL2 Predicts Survival in Germinal Center B-cell-like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab
- (2011) J. Iqbal et al. CLINICAL CANCER RESEARCH
- B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome
- (2011) Shaoying Li et al. MODERN PATHOLOGY
- Advances in the understanding of MYC-induced lymphomagenesis
- (2010) Kay Klapproth et al. BRITISH JOURNAL OF HAEMATOLOGY
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20+B-Cell Lymphoma in the Rituximab Era
- (2010) Marita Ziepert et al. JOURNAL OF CLINICAL ONCOLOGY
- Alteration of MicroRNAs Regulated by c-Myc in Burkitt Lymphoma
- (2010) Anna Onnis et al. PLoS One
- Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP
- (2008) L. M. Rimsza et al. BLOOD
- MYCtranslocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation
- (2008) E Leucci et al. JOURNAL OF PATHOLOGY
- Stromal Gene Signatures in Large-B-Cell Lymphomas
- (2008) G. Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
- (2008) G. Lenz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started